NIDDK. Proceedings of the national institute of diabetes and digestive and kidney disease international symposium on epidemiologic issues in urinary incontinence in women. Am J OB GYN 2003;188:77-8.
A new questionnaire to assess the quality of life of urinary incontinent women
Kelleher CJ, Cardozo LD, Khullar V, et al. A new questionnaire to assess the quality of life of urinary incontinent women. Br J Ob Gyn 1997; 104:1374-79.
Global ratings of patient satisfaction and perception of improvement with treatment for stress urinary incontinence: Validation of three global patient ratings
Burgio KL, Goode PS, Richter HE, et al. Global ratings of patient satisfaction and perception of improvement with treatment for stress urinary incontinence: Validation of three global patient ratings. Neurourol Urodyn 2006; 25:411-7.
Normative Values for American Urological Association Symptom Index (AUA-7) and Short form Urogenital Distress Inventory (UDI-6) in Patients 65 and Older Presenting for Non-Urological Care
Svatek R, Roche V, Thornberg J, et al. Normative Values for American Urological Association Symptom Index (AUA-7) and Short form Urogenital Distress Inventory (UDI-6) in Patients 65 and Older Presenting for Non-Urological Care. Neurourol Urodyn 2005;24:606-10.
American urological association symptom index for lower urinary tract symptoms in women: Correlation with degree of bother and impact on quality of life
Scarpero HM. American urological association symptom index for lower urinary tract symptoms in women: Correlation with degree of bother and impact on quality of life. Urology 2003;61:1118-22.
Duloxetine reduces the frequency of stress urinary incontinence episodes and improved quality of life in North American women. Evidence Based
Chancellor M, Dmochowski RR, Norton PA, et al. Duloxetine reduces the frequency of stress urinary incontinence episodes and improved quality of life in North American women. Evidence Based Obstet Gynecol 2004; 6:196-99.